Publications found:
512,290
Sort by:
The 2027-2032 World Outlook for Heart Pump Devices
US$ 1,195.00
This study covers the world outlook for heart pump devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Heart Pumps
US$ 1,195.00
This study covers the world outlook for heart pumps across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Heart Valve Devices
US$ 1,195.00
This study covers the world outlook for heart valve devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Heart Valves
US$ 1,195.00
This study covers the world outlook for heart valves across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Heat Stress Monitors
US$ 1,195.00
This study covers the world outlook for heat stress monitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hemarrhoid Treatments
US$ 1,195.00
This study covers the world outlook for hemarrhoid treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Hematocrit Test Devices
US$ 1,195.00
This study covers the world outlook for hematocrit test devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Hematology Diagnostics
US$ 1,195.00
This study covers the world outlook for hematology diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hemodynamic Monitoring
US$ 1,195.00
This study covers the world outlook for hemodynamic monitoring across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hemoglobin A1C Monitoring
US$ 1,195.00
This study covers the world outlook for hemoglobin A1C monitoring across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
288 pages
The 2027-2032 World Outlook for Hemoglobin A1C Testing
US$ 1,195.00
This study covers the world outlook for hemoglobin A1C testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hemoglobin Testing
US$ 1,195.00
This study covers the world outlook for hemoglobin testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia a Drugs
US$ 1,195.00
This study covers the world outlook for hemophilia a drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia a Treatments
US$ 1,195.00
This study covers the world outlook for hemophilia a treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia Drugs
US$ 1,195.00
This study covers the world outlook for hemophilia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Hemophilia Treatments
US$ 1,195.00
This study covers the world outlook for hemophilia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Analyzers
US$ 1,195.00
This study covers the world outlook for hemostasis analyzers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Diagnostics
US$ 1,195.00
This study covers the world outlook for hemostasis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Products
US$ 1,195.00
This study covers the world outlook for hemostasis products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostasis Valves
US$ 1,195.00
This study covers the world outlook for hemostasis valves across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostatic Agents
US$ 1,195.00
This study covers the world outlook for hemostatic agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Hemostats and Sealants
US$ 1,195.00
This study covers the world outlook for hemostats and sealants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Heparin
US$ 1,195.00
This study covers the world outlook for heparin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun...
January 2026
287 pages
The 2027-2032 World Outlook for Heparin Anticoagulants
US$ 1,195.00
This study covers the world outlook for heparin anticoagulants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Heparin Sodium
US$ 1,195.00
This study covers the world outlook for heparin sodium across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis B Diagnostic Tests
US$ 1,195.00
This study covers the world outlook for hepatitis b diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis B Vaccines
US$ 1,195.00
This study covers the world outlook for hepatitis b vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis C Drugs
US$ 1,195.00
This study covers the world outlook for hepatitis c drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis C Therapeutics
US$ 1,195.00
This study covers the world outlook for hepatitis c therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis Diagnostics
US$ 1,195.00
This study covers the world outlook for hepatitis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Hepatitis Therapeutics
US$ 1,195.00
This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for HER2 Antibodies
US$ 1,195.00
This study covers the world outlook for HER2 antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
The 2027-2032 World Outlook for Herbal Medicinal Products
US$ 1,195.00
This study covers the world outlook for herbal medicinal products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
288 pages
The 2027-2032 World Outlook for Herbal Medicines
US$ 1,195.00
This study covers the world outlook for herbal medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
